Effect of Nishatriphala yoga on HbA1c level in Madhumeha (Diabetes Mellitus)

A randomised controlled clinical trial to evaluate the effect of Nishatriphala yoga on HbA1c level in the management of Madhumeha w.s.r. to Diabetes Mellitus - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058064

Enrollment

Registered

2023-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Subjects with classical sign and symptoms of Madhumeha and Type-2 Diabetes Mellitus. • HbA1C level more than 6.5%. • On-going antidiabetic treatment at least 3 weeks. • Patient willing to sign and give consent.

Exclusion criteria

Exclusion criteria: • Patient of IDDM (Type-1 DM), Juvenile Diabetes and gestational diabetes mellitus will be excluded. • Diabetic Patient with co-morbidities, which are life threatening or interferes with the intervention. • Pregnant and Lactating mother will be excluded.

Design outcomes

Primary

Measure	Time frame
Effect of trail drug over the classical symptoms of Madhumeha and HbA1c levelTimepoint: 30 day 60 day 90 day	—

Secondary

Measure	Time frame
Assessment of Safety of Drug and Adverse drug reactions Aggravation of the symptoms of MadhumehaTimepoint: 30day, 60day, 90day	—

Countries

India

Contacts

Public ContactDr Vijaylaxmi B Hiremath

Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

drmsb123@rediffmail.com9036701207

Outcome results